October 28 - 29, 2015
This 2-day colloquium will explore challenges surrounding pre-approval access to investigational medicines in a series of debates featuring prominent representatives of governments, pharmaceutical companies, patient groups, NGOs, and foundations.
Friday, June 19, 2015 | 8:00 AM - 5:30 PM
Speakers: Joel Ackelsberg (NYC Department of Health and Mental Hygiene), Eric Alm (Center for Microbiome Informatics and Therapeutics, Massachusetts Institute of Technology), Martin J. Blaser (New York University Langone Medical Center), Ilana Brito (Massachusetts Institute of Technology), Jane Carlton (New York University Center for Genomics and Systems Biology), Rumi Chunara (New York University Polytechnic School of Engineering), Laurie Garrett (Council on Foreign Relations), Jack Gilbert (Argonne National Laboratory), Jo Handelsman (White House Office of Science and Technology Policy), Curtis Huttenhower (Harvard T.H. Chan School of Public Health), W. Ian Lipkin (Center for Infection and Immunity, Columbia University), Juan Maestre (The University of Texas at Austin), Christopher Mason (Institute for Computational Biomedicine, Weill Cornell Medical College), Paula Olsiewski (Alfred P. Sloan Foundation), Rachel Poretsky (University of Illinois at Chicago), Coby Schal (North Carolina State University Department of Entomology)
Efforts to map all of the genetic information of microbial communities that make up the urban genome—from kiosks and subways, to soil and sewage—seek to improve the health and productivity of the built environments in which we live.
Monday, May 5, 2014 | 7:30 AM - 3:00 PM
Speakers: Fareed Abdullah (South African National AIDS Council, Pretoria, South Africa), Frederick Altice (Yale School of Medicine, New Haven, CT, USA), Joe Amon (Human Rights Watch, New York, NY, USA), Chasity Andrews (Aaron Diamond AIDS Research Center, New York, NY, USA), Chris Beyrer (Johns Hopkins Bloomberg School of Public Health, Baltimore, PA, USA), Frances Cowan (Centre for Sexual Health and HIV/AIDS Research Zimbabwe, Zimbabwe), Anna-Louise Crago (University of Toronto, Canada), Steven Deeks (University of California - San Francisco, CA, USA), Jerome Kim (Walter Reed Army Institute of Research, Bethesda, MD, USA), Luiz Loures (UNAIDS, Geneva, Switzerland), Kristen Marks (Weill Cornell Medical College, New York, NY, USA), Daniel Raymond (Harm Reduction Coalition, New York, NY, USA), Pavlo Smyrnov (International HIV/AIDS Alliance in Ukraine, Ukraine)
The UNAIDS' vision of zero new HIV infections, zero AIDS-related deaths and zero discrimination provides a clear path for HIV research and policy. This symposium convenes clinicians, scientists, activists and policy-makers with the shared goal of improving outcomes for HIV in key vulnerable populations.
Wednesday, February 5, 2014 | 7:00 PM - 8:30 PM
Featuring: Allan Kellehear, Jeffrey J. Kripal, and Lani Leary
Moderator: Steve Paulson
How do we cope with the inevitability of our mortality? Experts in psychology, philosophy and sociology come together to share a multicultural perspective on death, dying, and what lies beyond.
Wednesday, December 11, 2013 | 7:00 PM - 8:30 PM
Featuring: Peter Fenwick, Kevin Nelson, Mary Neal, Sam Parnia
Moderator: Steve Paulson
What happens when we die? Recent medical advances have led to increased reports of "out of body" or "near death" experiences. Can these experiences be explained, and what can we learn from the transformative accounts of those who have nearly died?
Edited by Annals of the New York Academy of Sciences
This Annals volume presents a thought-provoking four-part series on the intersection of life and death, with a special emphasis on implications for how we understand and approach mortality from scientific, ethical, and spiritual perspectives.
Organizers: Chris Beyrer (Johns Hopkins Bloomberg School of Public Health), Peter Godfrey-Faussett (UNAIDS), Ani Shakarishvili (UNAIDS), Yegor Voronin (Global HIV Vaccine Enterprise), and Jennifer Henry (The New York Academy of Sciences)
The UNAIDS vision of zero new HIV infections, zero AIDS-related deaths, and zero discrimination calls for a global approach to HIV research and policy. This eBriefing focuses on improving outcomes for HIV in key vulnerable populations.
Keynote Speaker: Robert J. Greenberg (Alfred E. Mann Foundation)
This eBriefing explores the translation of neurotechnologies into new treatment options for neurological and psychiatric diseases.
Edited by Oscar Vilarroya
and Adolf Tobeña
(Universitat Autònoma de Barcelona, Barcelona, Spain)
This Annals volume explores timely topics in neuroethics, a developing scientific field addressing the neurobiological bases of critical sociological issues.
A recent conference held at the Academy asked a downright outrageous question: Can dementia be prevented by making changes to your diet? In this podcast we look at what the answers might be.
In the second of a two-part series, experts look at the links between health and nutrition. They examine everything from how nutrition impacts hospital stays, to cancer and aging, to developing food science innovations, and improving diet.
In this first of a two-part series, experts from various sectors explore the available options to reduce "hidden hunger"—micronutrient deficiencies in a population.